Mohammed Fahim Mohammed
Research Subjects
Mohammed Fahim Mohammed has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Ahmed Alharthy
Department of Radiology, Vancouver General Hospital, University of British Columbia, Vancouver, Canada
1 shared publicationAlison Harris
Department of Radiology, Vancouver General Hospital, 899 W 12th Ave, Vancouver, BC V5Z 1M9, Canada
1 shared publication- Bader AlMutairi
NGHA, Riyadh, Saudi Arabia
1 shared publication David Ferguson
Department of Radiology, Vancouver General Hospital, 899 W 12th Ave, Vancouver, BC V5Z 1M9, Canada
1 shared publication- Dominik Nakhostin
From the Diagnostic and Interventional Radiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland (A.M.T.G., V.M., T.S., M.P., D.N., G.P., H.A., A.E.); and Department of Radiology, Kantonsspital Baden, Baden, Switzerland (A.E.).
1 shared publication Faisal Khosa
Department of Radiology, Vancouver General Hospital, 899 W 12th Ave, Vancouver, BC V5Z 1M9, Canada
1 shared publication
Latest Publications
- 30 April 2022
- Published by Springer Nature
- p. 109-125
Neuroradiological Imaging
- 1 September 2021
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 217 (3) , 663
Editorial Comment: Dual-Energy CT for Gastrointestinal Imaging—Transitioning From Novelty to Must-Have Tool in the Radiologist's Armamentarium
This Editorial Comment discusses the following AJR article: Clinical Implementation of Dual-Energy CT for Gastrointestinal Imaging.
- 1 September 2021
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 217 (3) , 663
Editorial Comment: Dual-Energy CT for Gastrointestinal Imaging—Transitioning From Novelty to Must-Have Tool in the Radiologist's Armamentarium
This Editorial Comment discusses the following AJR article: Clinical Implementation of Dual-Energy CT for Gastrointestinal Imaging.
- Open Access
- 1 March 2021
- Published by Elsevier in Radiology Case Reports
- Vol. 16 (3) , 560-563
Retrohepatic IVC injury: A new treatment approach with arterial stent graft
- 1 March 2021
- Published by Elsevier in Radiology Case Reports
- Vol. 16 (3) , 560-563
Open AccessRetrohepatic IVC injury: A new treatment approach with arterial stent graft
- 1 May 2018
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 210 (5) , 1073-1078
Pheochromocytomas Versus Adenoma: Role of Venous Phase CT Enhancement
OBJECTIVE. Our objective was to investigate whether the quantitative measurement of venous phase enhancement on CT can distinguish a pheochromocytoma from an adrenal adenoma. MATERIALS AND METHODS. A pathology database was retrospectively appraised over a period of 7 years and revealed 43 histopathologically proven adrenal adenomas and 34 pheochromocytomas. The lesion densities were measured on the 60-second venous phase CT on all adrenal lesions to assess venous phase enhancement values. RESULTS. Venous phase enhancement of 85 HU or greater afforded a sensitivity, specificity, positive predictive value, and negative predictive value of 88.2%, 83.7%, 81.1%, and 90%, respectively (p < 0.0001). The positive likelihood ratio was 5.42. Venous phase enhancement of ≥ 85 HU was detected in 30 (88.2%) pheochromocytomas (p < 0.001) and in seven (16.3%) adenomas. Venous phase enhancement of < 85 HU was detected in four (11.8%) pheochromocytomas and in 36 (83.7%) adenomas. Of the pheochromocytomas imaged with a trip...
- 1 May 2018
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 210 (5) , 1073-1078
Pheochromocytomas Versus Adenoma: Role of Venous Phase CT Enhancement
OBJECTIVE. Our objective was to investigate whether the quantitative measurement of venous phase enhancement on CT can distinguish a pheochromocytoma from an adrenal adenoma. MATERIALS AND METHODS. A pathology database was retrospectively appraised over a period of 7 years and revealed 43 histopathologically proven adrenal adenomas and 34 pheochromocytomas. The lesion densities were measured on the 60-second venous phase CT on all adrenal lesions to assess venous phase enhancement values. RESULTS. Venous phase enhancement of 85 HU or greater afforded a sensitivity, specificity, positive predictive value, and negative predictive value of 88.2%, 83.7%, 81.1%, and 90%, respectively (p < 0.0001). The positive likelihood ratio was 5.42. Venous phase enhancement of ≥ 85 HU was detected in 30 (88.2%) pheochromocytomas (p < 0.001) and in seven (16.3%) adenomas. Venous phase enhancement of < 85 HU was detected in four (11.8%) pheochromocytomas and in 36 (83.7%) adenomas. Of the pheochromocytomas imaged with a trip...
- 12 July 2017
- Published by Springer Nature in Current Radiology Reports
- Vol. 5 (9) , 1-12
Imaging the Spine with Dual-Energy CT
- 12 July 2017
- Published by Springer Nature in Current Radiology Reports
- Vol. 5 (9) , 1-12
Imaging the Spine with Dual-Energy CT